Order Entry
Canada
ContactUsLinkComponent
Human Recombinant ADAM22 (from CHO cells)
Human Recombinant ADAM22 (from CHO cells)
Catalog # 102876-516
Supplier:  R&D Systems
CAS Number:  
Human Recombinant ADAM22 (from CHO cells)
Catalog # 102876-516
Supplier:  R&D Systems
Supplier Number:  4908-AD-050
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/ca/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Conjugation:
    Unconjugated
  • Protein/peptide type:
    Recombinant
  • Source:
    CHO cells
  • Species:
    Human
  • Size:
    50 μg
  • Storage conditions:
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
  • Endotoxin content:
    <0.10 EU per 1 ╡g of the protein by the LAL method.
  • Gene ID:
    53616
  • Protein synonyms:
    disintegrin-like|and cysteine-rich protein 2|MDC2|metalloproteinase-disintegrin ADAM22-3|ADAM 22|MGC149832|metalloproteinase-like|ADAM metallopeptidase domain 22
  • Accession no.:
    Q9P0K1
  • Protein/peptide name:
    ADAM22
  • Purity:
    >90%, by SDS-PAGE under reducing conditions and visualized by silver stain
  • Molecular weight:
    40-45 kDa & 69-80 kDa, reducing conditions
  • Cat. no.:
    102876-516
  • Supplier No.:
    4908-AD-050

Specifications

About this item

The Recombinant Human ADAM22 Protein from R&D Systems is derived from CHO. The Recombinant Human ADAM22 Protein has been validated for the following applications: Bioactivity.